S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

NEW YORK, December 30, 2025, 13:22 ET — Regular session

  • U.S. stocks trade narrowly mixed in holiday-thin volumes as investors wait for Fed minutes
  • Meta rises after saying it will acquire AI startup Manus
  • Traders watch for signals on 2026 rate cuts after a divided December decision

U.S. stocks edged lower in holiday-thin trade on Tuesday, with the S&P 500 and Nasdaq near flat as investors waited for the Federal Reserve’s meeting minutes. Meta Platforms rose after saying it will buy AI startup Manus, helping support communication services shares. At 12:00 p.m. ET, the Dow fell 0.24%, the S&P 500 slipped 0.09% and the Nasdaq Composite eased 0.07%. Reuters

The quiet tape matters because markets are closing out the year near record levels, and light volume can exaggerate otherwise small moves. The pause follows Monday’s pullback in heavyweight technology shares after last week’s gains pushed the S&P 500 to fresh highs. Reuters

Traders are focused on the Fed’s December 9–10 meeting minutes due later Tuesday, a release that often resets expectations for the path of rates. The central bank’s latest 25-basis-point cut — 0.25 percentage point — took the target range to 3.50%–3.75% and drew three dissenting votes, Reuters reported. Reuters

Meta shares were up about 1.2% in midday trading.

Meta said on Monday it would acquire Chinese-founded artificial intelligence startup Manus, stepping up efforts to fold more advanced AI into its products. Financial terms were not disclosed, but a source with direct knowledge said the deal values Singapore-based Manus at $2 billion to $3 billion; Manus has also struck a strategic partnership with Alibaba, Reuters reported. “We see a natural fit into Meta’s fast-growing, WhatsApp SMB (small, medium business) footprint,” Barton Crockett, an analyst at Rosenblatt Securities, said. Reuters

Other mega-cap tech was softer. Apple fell about 0.3% and Nvidia eased roughly 0.2%, while Microsoft edged up about 0.2%.

Financials also leaned on the Dow. Goldman Sachs slipped about 1% and American Express was down around 0.2%.

In the clean-energy complex, T1 Energy said it completed a $160 million sale of Section 45X production tax credits to an investment-grade buyer. Section 45X credits are U.S. incentives tied to domestic manufacturing of certain clean-energy components, and companies can sell them to raise cash. T1 Energy

T1 Energy shares gained about 3.7%.

With the minutes still ahead, investors are also watching year-end positioning in a shortened holiday week. Portfolio managers sometimes “window dress” at quarter-end by trimming losers and adding recent winners to make holdings look stronger in reports.

The next catalyst is the Fed minutes themselves: any hint on how officials weighed sticky inflation against softening data could move Treasury yields and, in turn, rate-sensitive stocks. Traders are also watching whether the late-December seasonal bid often dubbed the Santa Claus rally shows up in the first trading days of 2026.

Stock Market Today

  • Two under-$10 stocks that could double in 2026: Opendoor Technologies and Sweetgreen
    December 30, 2025, 5:25 PM EST. Two under-$10 names could double in 2026: Opendoor Technologies and Sweetgreen. Through late December, Opendoor was up about 260% in 2025 after a management reshuffle and a turnaround plan aimed at break-even on adjusted net income by year-end 2026. With mortgage rates around 6% and signs housing demand could recover, the stock's upside hinges on macro strength and execution. Sweetgreen faces a tougher year, but easier year-over-year comparisons and potential improvements in same-store sales could spark a rebound if the broader economy cooperates. The prospect of a double is speculative and relies on favorable macro conditions; as of Dec. 29, 14 S&P 500 components had doubled this year.
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading
Previous Story

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus
Next Story

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Go toTop